Platelet inhibition to target reperfusion injury trial: Rationale and study design
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Platelet inhibition to target reperfusion injury trial: Rationale and study design
Authors
Keywords
-
Journal
CLINICAL CARDIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-11-13
DOI
10.1002/clc.23110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiovascular Magnetic Resonance in Acute ST-Segment–Elevation Myocardial Infarction
- (2018) Heerajnarain Bulluck et al. CIRCULATION
- Cangrelor in Ticagrelor-Loaded STEMI Patients Undergoing Primary Percutaneous Coronary Intervention
- (2018) Dimitrios Alexopoulos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
- (2017) Muthiah Vaduganathan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- How Long Does It Take for Clopidogrel and Ticagrelor to Inhibit Platelets in Patients Undergoing Primary Percutaneous Coronary Intervention? A Detailed Pharmacodynamic Analysis: Time Course of Platelet Reactivity in STEMI (TOPS)
- (2017) Thomas Bergmeijer et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Myocardial Infarct Size by CMR in Clinical Cardioprotection Studies
- (2017) Heerajnarain Bulluck et al. JACC-Cardiovascular Imaging
- Cangrelor-Mediated Cardioprotection Requires Platelets and Sphingosine Phosphorylation
- (2016) Michael V. Cohen et al. CARDIOVASCULAR DRUGS AND THERAPY
- Protective Effects of Ticagrelor on Myocardial Injury After InfarctionClinical Perspective
- (2016) Gemma Vilahur et al. CIRCULATION
- Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction
- (2016) Moman A. Mohammad et al. PLATELETS
- Ticagrelor Protects the Heart Against Reperfusion Injury and Improves Remodeling After Myocardial InfarctionSignificance
- (2015) Yumei Ye et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Mitochondrially targeted Endonuclease III has a powerful anti-infarct effect in an in vivo rat model of myocardial ischemia/reperfusion
- (2015) Xi-Ming Yang et al. BASIC RESEARCH IN CARDIOLOGY
- Cardioprotective Properties of the Platelet P2Y12 Receptor Inhibitor, Cangrelor: Protective in Diabetics and Reliant Upon the Presence of Blood
- (2015) R. M. Bell et al. CARDIOVASCULAR DRUGS AND THERAPY
- Reducing myocardial infarct size: challenges and future opportunities
- (2015) Heerajnarain Bulluck et al. HEART
- Cyclosporine before PCI in Patients with Acute Myocardial Infarction
- (2015) Thien-Tri Cung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obstrucción microvascular: el azote de la reperfusión miocárdica
- (2015) Heerajnarain Bulluck et al. REVISTA ESPANOLA DE CARDIOLOGIA
- A pharmacodynamic study of the optimal P2Y12inhibitor regimen for East Asian patients with acute coronary syndrome
- (2015) Ji Hyun Lee et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Chronic Treatment With Ticagrelor Limits Myocardial Infarct Size
- (2014) Manjyot K. Nanhwan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI)
- (2014) N. Siddiqi et al. EUROPEAN HEART JOURNAL
- Cangrelor: Review of the Drug and the CHAMPION Programme (Including PHOENIX)
- (2014) Marcello Marino et al. Current Cardiology Reports
- Cardioprotective Effects of Exenatide in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
- (2013) Jong Shin Woo et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Two Classes of Anti-Platelet Drugs Reduce Anatomical Infarct Size in Monkey Hearts
- (2013) Xi-Ming Yang et al. CARDIOVASCULAR DRUGS AND THERAPY
- Triple Therapy Greatly Increases Myocardial Salvage During Ischemia/Reperfusion in the in situ Rat Heart
- (2013) Xi-Ming Yang et al. CARDIOVASCULAR DRUGS AND THERAPY
- Comparison of Prasugrel and Ticagrelor Loading Doses in ST-Segment Elevation Myocardial Infarction Patients
- (2013) Guido Parodi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention
- (2013) Philippe Généreux et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events
- (2013) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduced immediate ischemic events with cangrelor in PCI: A pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction
- (2012) Harvey D. White et al. AMERICAN HEART JOURNAL
- Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients with ST-Segment–Elevation Myocardial Infarction
- (2012) Dimitrios Alexopoulos et al. Circulation-Cardiovascular Interventions
- Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging
- (2012) Steven K White et al. HEART
- Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial
- (2012) Giuseppe Tarantini et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Platelet P2Y12 Blockers Confer Direct Postconditioning-Like Protection in Reperfused Rabbit Hearts
- (2012) Xi-Ming Yang et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention
- (2012) S. BISCAGLIA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Standardized Bleeding Definitions for Cardiovascular Clinical Trials
- (2011) Roxana Mehran et al. CIRCULATION
- Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention
- (2011) X. Freixa et al. EUROPEAN HEART JOURNAL
- Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction
- (2011) Jacob Lønborg et al. EUROPEAN HEART JOURNAL
- Cardioprotective Effects of Ischemic Postconditioning in Patients Treated With Primary Percutaneous Coronary Intervention, Evaluated by Magnetic Resonance
- (2010) Jacob L�nborg et al. Circulation-Cardiovascular Interventions
- Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
- (2010) J. M. Siller-Matula et al. HEART
- Bedside Evaluation of Thienopyridine Antiplatelet Therapy
- (2009) Matthew J. Price CIRCULATION
- Pharmacokinetics and Pharmacodynamics of a Bolus and Infusion of Cangrelor: A Direct, Parenteral P2Y12 Receptor Antagonist
- (2009) Wendell S. Akers et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Intravenous Platelet Blockade with Cangrelor during PCI
- (2009) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platelet Inhibition with Cangrelor in Patients Undergoing PCI
- (2009) Robert A. Harrington et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search